ACU-234

N/A

Report date: 2026/01/15 16:22:01

Base Information

Drug NameACU-234
Drug Alias NameACU-234ACU234
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAmyloid beta-protein precursor inhibitors
TargetsAmyloid beta-protein precursor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcumen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesJcr Pharmaceuticals Co LtdAcumen Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A